There are no Transcripts on GNOM.
at MarketWatch.com (Nov 26, 2012)
at MarketWatch.com (Oct 15, 2012)
at MarketWatch.com (Sep 17, 2012)
at Fox Business (Aug 31, 2012)
at MarketWatch.com (Jun 5, 2012)
at MarketWatch.com (Feb 13, 2012)
at MarketWatch.com (Jan 10, 2012)
May. 8, 2012, 3:57 PM
Mar. 8, 2012, 6:25 PMComplete Genomics (GNOM) reverses late session gains to trade lower in the post session after reporting a Q4 loss of $0.67 per share, compared with the prior-year period's $0.69 loss per share. Revenues were $2.5M, down 34% from $3.8M in the same quarter last year. The Street was expecting a loss of $0.65 on revenues of $3.15M. Shares -2.1% AH. | Comment!
GNOM vs. ETF Alternatives
Other News & PR